• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单细胞分辨率下对新冠病毒宿主免疫的洞察。

An insight into COVID-19 host immunity at single-cell resolution.

作者信息

Ghosh Supratim, Chatterjee Ankita, Maitra Arindam

机构信息

Biotechnology Research and Innovation Council - National Institute of Biomedical Genomics, Kalyani, India.

Regional Centre for Biotechnology, Faridabad, India.

出版信息

Int Rev Immunol. 2025;44(4):180-195. doi: 10.1080/08830185.2024.2443420. Epub 2024 Dec 21.

DOI:10.1080/08830185.2024.2443420
PMID:39707914
Abstract

Host immunity helps the body to fight against COVID-19. Single-cell transcriptomics has provided the scope of investigating cellular and molecular underpinnings of host immune response against SARS-CoV-2 infection at high resolution. In this review, we have systematically described the virus-induced dysregulation of relative abundance as well as molecular behavior of each innate and adaptive immune cell type and cell state during COVID-19 infection and for different vaccinations, based on single-cell studies published in last three-four years. Identification and characterization of these disease-associated specific cell populations might help to design better, efficient, and targeted therapeutic avenues.

摘要

宿主免疫力有助于身体对抗新冠病毒。单细胞转录组学为高分辨率研究宿主针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的免疫反应的细胞和分子基础提供了范围。在本综述中,我们基于过去三到四年发表的单细胞研究,系统地描述了在新冠病毒感染期间以及不同疫苗接种情况下,每种固有免疫和适应性免疫细胞类型及细胞状态的病毒诱导的相对丰度失调以及分子行为。鉴定和表征这些与疾病相关的特定细胞群体可能有助于设计出更好、更有效且有针对性的治疗途径。

相似文献

1
An insight into COVID-19 host immunity at single-cell resolution.单细胞分辨率下对新冠病毒宿主免疫的洞察。
Int Rev Immunol. 2025;44(4):180-195. doi: 10.1080/08830185.2024.2443420. Epub 2024 Dec 21.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
6
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
7
Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection.基于实验室的分子检测替代 RT-PCR 用于 SARS-CoV-2 感染的诊断。
Cochrane Database Syst Rev. 2024 Oct 14;10(10):CD015618. doi: 10.1002/14651858.CD015618.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
10
Adapting COVID-19 research infrastructure to capture influenza and respiratory syncytial virus alongside SARS-CoV-2 in UK healthcare workers winter 2022/23 and beyond: protocol for a pragmatic sub-study.调整新冠病毒研究基础设施,以便在2022/23年冬季及以后在英国医护人员中同时收集流感病毒、呼吸道合胞病毒以及严重急性呼吸综合征冠状病毒2:一项务实子研究的方案
NIHR Open Res. 2024 Nov 5;4:1. doi: 10.3310/nihropenres.13517.2. eCollection 2024.